| [1] |
张雨晴．中国胃肠胰腺神经内分泌肿瘤的十年回顾性临床流行病学研究[D]．北京：北京协和医学院中国医学科学院，2016.
|
| [2] |
Halfdanarson TR, Rubin J, Farnell MB, et al. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors[J]. Endocr Relat Cancer, 2008, 15(2):409-427.
|
| [3] |
Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States[J]. JAMA Oncol, 2017, 3(10):1335-1342.
|
| [4] |
Partelli S, Giannone F, Schiavo Lena M, et al. Is the real prevalence of pancreatic neuroendocrine tumors underestimated? a retrospective study on a large series of pancreatic specimens[J]. Neuroendocrinology, 2019, 109(2):165-170.
|
| [5] |
Riihimäki M, Hemminki A, Sundquist K, et al. The epidemiology of metastases in neuroendocrine tumors[J]. Int J Cancer, 2016, 139(12):2679-2686.
|
| [6] |
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2):182-188.
|
| [7] |
Partelli S, Bartsch DK, Capdevila J, et al. ENETS Consensus Guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours[J]. Neuroendocrinology, 2017, 105(3):255-265.
|
| [8] |
Song L, Zhai X, Yu S, et al. Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: a single-center study[J]. Cancer Med, 2019, 8(8):3729-3737.
|
| [9] |
Yuan CH, Wang J, Xiu DR, et al. Meta-analysis of liver resection versus nonsurgical treatments for pancreatic neuroendocrine tumors with liver metastases[J]. Ann Surg Oncol, 2016, 23(1):244-249.
|
| [10] |
Tao M, Yuan C, Xiu D, et al. Analysis of risk factors affecting the prognosis of pancreatic neuroendocrine tumors[J]. Chin Med J, 2014, 127(16):2924-2928.
|
| [11] |
Tao L, Xiu D, Sadula A, et al. Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases[J]. Oncotarget, 2017, 8(45):79785-79792.
|
| [12] |
Kose E, Kahramangil B, Aydin H, et al. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience[J]. Surg Endosc, 2019, DOI: 10.1007/s00464-019-06759-1[Epub ahead of print]. |
| [13] |
Pavel M, O'Toole D, Costa F, et al. ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site[J]. Neuroendocrinology, 2016, 103(2):172-185.
|
| [14] |
Bertani E, Fazio N, Radice D, et al. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. a propensity score survival evaluation[J]. Eur J Surg Oncol, 2017, 43(2):372-379.
|
| [15] |
Morgan RE, Pommier SJ, Pommier RF. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors[J].Surgery, 2018, 163(1):218-225.
|
| [16] |
Kennedy A, Bester L, Salem R, et al. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference[J]. HPB, 2015, 17(1):29-37.
|
| [17] |
Mazzaferro V, Sposito C, Coppa J, et al. The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors[J]. Am J Transplant, 2016, 16(10):2892-2902.
|
| [18] |
Spolverato G, Bagante F, Tsilimigras DI, et al. Liver transplantation in patients with liver metastases from neuroendocrine tumors[J]. Minerva Chir, 2019, 74(5):399-406.
|
| [19] |
Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer[J]. Oncotarget, 2015, 6(11):8491-8524.
|
| [20] |
Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis[J]. Ann Surg Oncol, 2010, 17(12):3129-3136.
URL
|
| [21] |
Lang H, de Santibañes E, Schlitt HJ, et al. 10th anniversary of ALPPS-lessons learned and quo vadis[J]. Ann Surg, 2019, 269(1):114-119.
|
| [22] |
Wu J, Sun C, Li E, et al. Non-functional pancreatic neuroendocrine tumours: emerging trends in incidence and mortality[J]. BMC Cancer, 2019, 19(1):334.
|